Little Green Pharma Ltd (ASX: LGP) has been awarded an Italian Government tender to deliver a shipment of EU GMP medicinal cannabis flower from its Danish Facility into Italy.
The shipment value of ~€200,000 is not material, however with the award LGP has joined a small group of international cannabis producers qualified to supply cannabis flower medicines into Italy, positioning LGP strongly for future upcoming Italian Government tenders.
Italy has a population of 60 million people and a Total Addressable Market estimated at ~A$10 billion.
Italian Government tenders impose some of the highest GMP product quality standards globally, with LGP one of only two suppliers bidding for the tender and with only Aurora having been successful in the past.
The shipment will be of historic inventory acquired as part of LGP’s purchase of its Danish Facility from Canopy Growth.
The Italian award builds on LGP’s growing momentum in European and UK markets, with LGP now having supplied products into Germany, France, the UK and Denmark as it also continues to progress product registration pathways into Greece and Poland.
